Search

everythinglearnresearchcommunity

for

Search:↓

The document says hair loss can happen after recovering from COVID-19 and it can cause psychological discomfort.

Recent discoveries have improved our understanding of hair loss, but challenges in treatment and knowledge among specialists still exist.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Experts discussed hair care, genetic hair defects, hair loss treatments, nail surgery, lupus treatments, skin infections, and cosmetic allergies.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

Healthcare organizations must seriously focus on strategic decision-making to succeed in a complex market.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

UK stem-cell clinics often mislead about treatment safety and effectiveness, needing better regulation.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.